Sandbox 54321
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
== Structure == | == Structure == | ||
| - | <scene name='74/745973/Lisinopril_zinc/1'>Lisinopril</scene>is a synthetic angiotensin-converting enzyme inhibitor (ACE inhibitors) with molecular formula of C21+H31+N3+O5, empirical formula of C21+H31+N3+O5*2H2O, and average molecular weight of 405.495 g/mol. It is primarily used for the treatment of hypertension. Lisinopril is typically in the trans isometric form because it has a lower steric repulsion between the hydroxyl and carboxyl groups than the cis conformation and is biologically active in this form | + | <scene name='74/745973/Lisinopril_zinc/1'>Lisinopril</scene>is a synthetic angiotensin-converting enzyme inhibitor (ACE inhibitors) with molecular formula of C21+H31+N3+O5, empirical formula of C21+H31+N3+O5*2H2O, and average molecular weight of 405.495 g/mol. It is primarily used for the treatment of hypertension<ref name="four">National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119 (accessed Nov. 12, 2016).</ref>. Lisinopril is typically in the trans isometric form because it has a lower steric repulsion between the hydroxyl and carboxyl groups than the cis conformation and is biologically active in this form <ref name= "five">Bouabdallah, S., Dhia, T. B., & Driss, R. (2014, February 25). Study of a Conformational Equilibrium of Lisinopril by HPLC, NMR, and DFT. Retrieved November 12, 2016, from https://www.hindawi.com/journals/ijac/2014/494719/ |
| + | </ref>.Lisinopril has a benzene ring and from there it has a 4-carbon amide chain where it branches of into a carboxylic acid group one way and a secondary amide group the other way which connects to the rest of the molecule. From the secondary amide, the molecule branches into a 5-carbon amine with a primary amide at the end. The other branch from the secondary amide has a ketone bonded to a nitrogen in a 4-carbon ring. From this carbon ring, there is a carboxylic acid group. | ||
== Relevance == | == Relevance == | ||
Revision as of 17:41, 12 November 2016
Cite error: Invalid <ref> tag;
refs with no name must have content==Your Heading Here (maybe something like 'Structure')== 0
| |||||||||||
References
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
- ↑ National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119
- ↑ Helen, Allen(2016). Lisinopril: Lisinopril ACE inhibitor. Patient. Retrieved from: http://patient.info/medicine/lisinopril-an-ace-inhibitor-zestril
- ↑ National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119 (accessed Nov. 12, 2016).
- ↑ Bouabdallah, S., Dhia, T. B., & Driss, R. (2014, February 25). Study of a Conformational Equilibrium of Lisinopril by HPLC, NMR, and DFT. Retrieved November 12, 2016, from https://www.hindawi.com/journals/ijac/2014/494719/
